Patient Leaflet Updated 26-May-2026 | SERB
DigiFab
DigiFab®, 40 mg/vial, Powder for solution for infusion
(referred to as DigiFab® hereafter in this leaflet).
digoxin immune Fab
In this leaflet:
1. What DigiFab® is and what it is used for
2. What you need to know before you are given DigiFab®
3. How DigiFab® will be given
4. Possible side effects
5. How DigiFab® will be stored
6. Contents of the pack and Further information
DigiFab® belongs to a group of medicines known as digitalis antitoxins. It is a preparation of protein fragments derived from antibodies produced in sheep. DigiFab® binds and neutralises digoxin and other digoxin-like substances.
DigiFab® solution is used to treat an overdose of digoxin and other digoxin-like substances, when stopping taking digoxin and other measures are not sufficient.
DigiFab® solution is also used to treat poisoning resulting from other digoxin-like substances, called cardiac glycosides, that can be found in certain plants.
You should not be given DigiFab® if you are allergic to DigiFab® or to any of the other ingredients of DigiFab® (for other ingredients see section 6 Other information).
Warnings and precautions. Before you are given DigiFab® you should tell your doctor if:
If any of the above apply to you then talk to your doctor who will decide what to do.
There is limited information on the use of DigiFab in children.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
There is no information on the use of DigiFab® in pregnant women or women who are breast-feeding. If you are pregnant, likely to become pregnant or are breast-feeding then you must tell your doctor before taking this medicine. Your doctor will have taken this into account before giving DigiFab®.
There is no information on whether DigiFab® affects the ability to drive or operate machines. Ask your doctor for advice.
Your doctor or nurse will usually give you DigiFab® by infusion into a vein. The powder in each vial will be dissolved in sterile water and may be further diluted with sterile saline solution.
Your doctor will calculate the amount of DigiFab® that you will be given depending on how much digoxin you have in your body. If the amount of digoxin or digoxin-like substance cannot be calculated, you will be treated with a set dose.
The usual initial dose for adults and children over 20 kg may vary between one vial (40 mg DigiFab®) and 5 vials (200 mg DigiFab®) depending on the type of substance responsible for overdose or poisoning. The dose used for small children under 20 kg will usually be less.
Your doctor will record the batch number of the DigiFab® given to you and this information will be kept in your patient file.
You will be monitored with blood tests and continuous heart monitoring during DigiFab® treatment and for at least 24 hours after DigiFab® treatment has been finished.
The MA holder is not aware of any patients who have suffered DigiFab® overdoses, so no information on overdose is available. However, if you think you have been given too much DigiFab® tell a doctor or nurse or pharmacist immediately.
If you have further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, DigiFab® can cause side effects, although not everybody gets them.
The following side effects are important and will require immediate action if you experience them. Tell your doctor or nurse immediately if you experience any of the following symptoms (you may need to stop DigiFab®):
The frequencies at which the above reactions occur are not stated.
The following side effects have also been reported:
Common, affecting up to 1 in 10 people:
Symptoms may occur up to 14 days after the infusion.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any Possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
You will be given DigiFab® in a hospital. The hospital will store the medicine correctly between 2 and 8°C. Not to be stored in a freezer.
After DigiFab® has been made up, it should be used immediately.
DigiFab® must not be used after the expiry date on the vial and outer carton. The hospital pharmacist will check this before he/she dispenses DigiFab®.
All medicines should be kept out of the reach and sight of children.
DigiFab® is supplied as a sterile, off-white powder in a clear glass vial, closed with a rubber stopper and aluminium flip top seal. Each vial contains 40mg digoxin immune Fab protein.
Each pack contains 1 vial.
The marketing authorisation holder is
This leaflet was last approved in July 2024.
DigiFab® is a registered trademark of BTG International Inc.
The SERB logo is a registered trademark of SERB S.à.r.l
PIL P21744G
00 33 1 73 03 20 00
http://www.serb-labo.com